Delivery Order SPE2DB24D2018-SPE2DB25FWVY8
- Not listed
- This is a $2,380.72 firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is for the pharmaceutical product BRIVIACT 25 MG TABLET 60S, with a period of performance through July 11, 2025. AmerisourceBergen is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to provide a wide range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,180.68 firm-fixed-price delivery order is for the supply of 4,566,322,547 units of BRIVIACT 25 MG Tablets. The contract has a completion date of November 5, 2024 and was awarded on November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $3,818.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The $1,702.34 firm fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, through its Corporate Office Division, will provide these prescription medications to support military treatment facilities and other federal healthcare programs. This delivery order is part of a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a global pharmaceutical distribution company, to provide BRIVIACT 100 MG TABLET 60S. The potential value of this contract is $2,382.26, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,687.28, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The order has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $5,572.14 firm fixed price delivery order is for the supply of 60 tablets of the medication BRIVIACT 100 MG. The contract has an ultimate completion date of May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of BRIVIACT 50 mg tablets and has a total ceiling value of $9,201.67 with an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BRIVIACT 50 MG TABLET 60S. This $1,639.10 award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 between DLA and Amerisourcebergen Drug Corp through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVY8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BRIVIACT 25 MG tablets (60-count units) with a ceiling value of $1,053.23. This firm fixed price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated extensive capability in fulfilling DLA medical supply needs through competitively awarded contracts. The company's federal contract portfolio encompasses a broad range of pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. This delivery order for BRIVIACT tablets reflects the company's ongoing role as a key supplier within the DLA's pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |